Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102510200 on June 14, 2001

J. Biol. Chem., Vol. 276, Issue 34, 32101-32108, August 24, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/34/32101    most recent
M102510200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fonseca, M. V.
Right arrow Articles by Escalante-Semerena, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fonseca, M. V.
Right arrow Articles by Escalante-Semerena, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An in Vitro Reducing System for the Enzymic Conversion of Cobalamin to Adenosylcobalamin*

Maris V. FonsecaDagger and Jorge C. Escalante-Semerena§

From the Department of Bacteriology, University of Wisconsin, Madison, Wisconsin 53706

Received for publication, March 20, 2001, and in revised form, June 11, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Homogeneous ferredoxin (flavodoxin):NADP+ reductase and flavodoxin A proteins served as electron donors for the reduction of co(III)rrinoids to co(I)rrinoids in vitro. The resulting co(I)rrinoids served as substrates for the ATP:co(I)rrinoid adenosyltransferase (CobA) enzyme of Salmonella enterica serovar Typhimurium LT2 and were converted to their respective adenosylated derivatives. The reaction products were isolated by reverse phase high performance liquid chromatography, and their identities were confirmed by UV-visible spectroscopy, mass spectrometry, and in vivo biological activity assays. Adenosylcobalamin generated by this system supported the activity of 1,2-propanediol dehydratase as effectively as authentic adenosylcobalamin. This is the first report of a protein system that can be coupled to the adenosyltransferase CobA enzyme for the conversion of co(III)rrinoids to their adenosylated derivatives.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Adenosylcobalamin (AdoCbl)1 is a structurally complex coenzyme (Fig. 1). Its biosynthesis has been studied in a number of procaryotes (1-5), where aerobic and anaerobic pathways for its generation have been identified (3, 5, 6). Conversion of biologically inactive forms of Cbl, such as CNCbl (vitamin B12) to AdoCbl must occur before it can function as a coenzyme. This conversion requires reduction of the cobalt atom in the corrin ring to its Co(I) state before it can be covalently attached to the 5'-deoxyadenosyl moiety from ATP to yield AdoCbl. The process was thought to require three enzymic activities (7): a cob(III)alamin reductase (EC 1.6.99.8), a cob(II)alamin reductase (EC 1.6.99.9), and an ATP:co(I)rrinoid adenosyltransferase (EC 2.5.1.17) (CobA in Salmonella enterica). The adenosyltransferase enzyme has been studied in several organisms (7-13). Recently, the three-dimensional structure of the CobA enzyme of S. enterica was solved in its apoenzyme form, complexed with MgATP, and complexed with HOCbl and MgATP (14), revealing a new mode for corrinoid binding that is substantially different from that of Cbl-dependent enzymes (15-18).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Chemical structure of AdoCbl.

The reducing system involved in the corrinoid adenosylation pathway is not well understood in any of the organisms in which Cbl biosynthesis has been studied. The corrinoid reducing activities described to date in procaryotes were reported to require pyridine nucleotides and free flavin nucleotides for activity (7, 8, 19), and thus activity has been attributed to easily dissociable flavoproteins. However, it was recently shown that co(III)rrinoid reduction can be chemically achieved by dihydroflavin nucleotides in the absence of any enzymes (20). The identity of the enzyme catalyzing the reduction of Co(II) to Co(I) remained unknown. Although a cob(II)yrinic acid a,c-diamide reductase was isolated from Pseudomonas denitrificans, neither the enzyme nor the gene responsible for this activity was identified (19).

At present, the only well documented cob(II)alamin reduction reaction is the one required for reductive activation of the E. coli methionine synthase enzyme (MetH). The MetH enzyme becomes inactive once every 2,000 turnovers when cob(I)alamin oxidizes to cob(II)alamin (21). The electrons for the reduction of cob(II)alamin to cob(I)alamin in MetH are provided by reduced flavodoxin (FldA) (22-24). It has been demonstrated that very specific interactions between FldA and MetH are required for cob(II)alamin reduction to occur (21, 24, 25). The data presented herein show that the NADP+:ferredoxin (flavodoxin) reductase (Fpr) and FldA proteins can reduce co(III)rrinoids to co(I)rrinoids, the substrates of the CobA. The results from spectroscopic analyses and enzymic and biological activity assays are reported to show that the product of the in vitro adenosylation reaction was the adenosylated derivative of the corrinoid substrate used. It is proposed that the Fpr and FldA proteins are part of the corrinoid adenosylation pathway in S. enterica.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents

Unless otherwise stated, all reagents including (CN)2Cbi, HOCbl, CNCbl, and AdoCbl were obtained from Sigma.

Protein Purification

Purification of E. coli Fpr

Step 1: Mass Culturing of the Overexpressing Strain and Generation of Cell-free Extracts-- Fpr protein was overproduced from strain JE4937 (E. coli C-1a/pEE1010, a gift from Elisabeth Haggård-Ljungquist, Stockholm University, Stockholm, Sweden) grown overnight at 37 °C on Luria Bertani broth containing 100 µg/ml of ampicillin and 30 mM glucose. The cells were harvested by centrifugation at 10,000 × g for 10 min using a Sorvall GSA rotor (DuPont Instruments, Wilmington, DE). Approximately 20 g of cells were resuspended in 50 mM Tris-Cl buffer pH 7.5 at 4 °C (buffer A) containing 16 µg/ml of protein inhibitor phenylmethanesulfonyl fluoride. The cell suspension was broken by sonication using a Sonic Dismembrator (model 550; Fisher) for 13 min (large tip, setting of 6, 50% duty). Cell-free extracts were generated by centrifugation at 40,000 × g using a KOMP Spin rotor (model KA-21.50; Composite RotorTM, Mountain View, CA) for 1.5 h.

Step 2: Anion Exchange Chromatography-- Cell-free extract (0.84 g of protein) was applied to a column containing DEAE 650M TSK TOYOPEARL® anion exchange resin (2.5 × 20 cm, 41.7-ml bed volume; equilibrated with buffer A; Tosohaas, Montgomeryville, PA). Twenty mg of protein was applied per ml of resin. The column was developed at a flow rate of 60 ml h-1. After the sample was applied, the column was washed with 170 ml of the buffer A, followed by a 65-ml wash with buffer A containing M NaCl. Purification of the Fpr protein was monitored by SDS-PAGE.

Step 3: Dye Ligand Chromatography-- Fractions from the previous step containing Fpr (254 mg of total protein) were applied to a Reactive Red 120 column (2.5 × 20 cm, 76-ml bed volume; Sigma) equilibrated with buffer A. Approximately 4 mg of protein was loaded per ml of resin. The column was developed at a flow rate of 79 ml h-1. After washing the column with 120 ml of buffer A, bound proteins were eluted with a 310-ml linear gradient of NaCl (0-1.0 M) in buffer A. Following the gradient, the column was washed with 240 ml of buffer A containing 1.3 M NaCl to elute tightly bound proteins. Fractions containing Fpr protein, as judged by SDS-PAGE and UV-visible spectrum of the enzyme-bound flavin, were pooled and concentrated using a Centriprep 10TM concentrator (Millipore, Bedford, MA).

Step 4: Anion Exchange FPLC-- Purified Fpr protein was applied to a Resource Q FPLC column (Amersha Pharmacia Biotech) equilibrated with buffer A at 41 mg/ml of resin. Proteins bound to this resin were eluted with a linear gradient of NaCl (0-1.0 M) in buffer A. After this purification step, the Fpr protein was assessed by SDS-PAGE to be >= 98% homogeneous. Eighteen mg of homogeneous Fpr protein was obtained from the starting 20 g of cell material.

Purification of E. coli FldA

Step 1: Overproduction of FldA Protein and Generation of Cell-free Extracts-- The flavodoxin protein was overproduced from four 2-liter cultures of E. coli strain DH1/pDHO2 (R. G. Matthews, University of Michigan) grown on LB broth containing 100 µg/ml of ampicillin. The cells were grown at 37 °C to an A650 of about 0.7. Isopropyl-beta -D-thiogalactoside was added to a final concentration of 400 µM, and the incubation was continued overnight. After incubation, the cells were harvested by centrifugation at 10,000 × g for 10 min using a Sorvall GSA rotor (DuPont), the cells (~25 g) were resuspended in 150 ml of 50 mM Tris-Cl buffer, pH 7.5, at 4 °C containing 16 µg of phenylmethanesulfonyl fluoride/ml of extract. The cells were broken by sonication using a sonic dismembrator for 7.5 min (large tip, setting of 6, 50% duty). The cell-free extracts were generated by centrifugation at 40,000 × g for 1.5 h using a KOMP Spin rotor.

Step 2: Anion Exchange Chromatography on DEAE-650M-- Cell-free extract (~1.5 g of protein) was applied to a column containing DEAE 650M resin (2.5 × 20 cm, 70-ml bed volume) equilibrated with buffer A. Approximately 22 mg of protein was applied per ml of resin. The column was washed with 70 ml of loading buffer followed by 140 ml of 100 mM sodium acetate buffer, pH 5.0. Bound proteins were eluted with a linear gradient 100-500 mM NaCl in 100 mM sodium acetate buffer, pH 5.0. The pH of the fractions containing the FldA protein was brought up to 7.0 with 2 M Tris-Cl buffer, pH 8.0, at 4 °C. Fractions containing the FldA protein were pooled and dialyzed against buffer A.

Step 3: Anion Exchange FPLC-- Fractions containing dialyzed FldA protein (~315 mg of total protein) were applied to a POROS HQ (PerSeptive Biosystems, Framingham, MA) anion exchange FPLC column (1.0 × 10 cm, 7-ml bed volume) equilibrated with buffer A. Forty-five mg of protein was applied per ml of resin. The column was washed with 14 ml of buffer A followed by a linear gradient of 0-1.5 M NaCl in buffer A. Fractions containing FldA were pooled, dialyzed against buffer A, and stored at -90 °C in buffer A + 20% (v/v) glycerol. After this purification step, the FldA protein was assessed to be >95% homogeneous by SDS-PAGE. A total of 85 mg of FldA was obtained from 25 g of starting material.

Purification of the CobA Enzyme of S. enterica Purification of the CobA enzyme was performed as described in Bauer et al. (14) without modifications.

Purification of the NAD(P)H:Flavin oxidoreductase (Fre) Enzyme Hexahistidine-tagged Fre enzyme (H6Fre) was purified to homogeneity as described (20).

Protein Techniques Total protein concentration was determined by the Bradford method using the Bio-Rad protein reagent (26). Protein analysis was performed by SDS-PAGE (27) stained with Coomassie Blue (28). The concentration of the Fpr and FldA proteins was determined using the reported extinction coefficients for the protein-bound flavins (29).

In Vitro Activity Assays

Corrinoid Adenosylation Assays Potassium borohydride-dependent CobA assays were performed as described (13). The assay that demanded enzymic reduction of cob(III)alamin to cob(I)alamin was a modification of the corrinoid adenosylation assay previously reported (13). Conversion of (HOCbl) to AdoCbl was monitored spectrophotometrically using a PerkinElmer Lambda 6 Spectrophotometer equipped with a temperature-regulated cuvette holder. The assay mixtures (final volume, 1 ml) contained HOCbl (50 nmol), NADPH (500 nmol), ATP (400 nmol), MnCl2 or MgCl2 (800 nmol), FMN (50 nmol), Tris-Cl buffer, pH 8.0, at 37 °C (200 µmol) homogeneous NAD(P)H:FMN oxidoreductase (Fre) enzyme (50 units, where 1 unit of flavin reductase activity was defined as the amount of enzyme required to reduce 1 nmol of FMN (epsilon 450 = 12,200 M-1 cm-1)/min) (20), and Fpr, FldA, and CobA proteins at various concentrations. Diacyanocob(III)inamide (CN)2Cbi) alone and (CN)2Cbi) with hydroxocob(III)inamide were used at a concentration of 20 µM when used as corrinoid substrates in place of HOCbl. The reaction mixtures were incubated at 37 °C in the spectrophotometer. In subsequent assays, the Fpr protein was used to reduce cob(III)alamin to cob(II)alamin, and thus FMN and Fre were omitted from these assays.

AdoCbl formation was monitored by the increase in the absorbance of the solution at 525 nm as a function of time. The amount of product generated was calculated using the difference in molar extinction coefficient between the substrate, cob(II)alamin, and the product, AdoCbl, at 525 nm (epsilon 525 = 4.8 × 10-3 M-1 cm-1). One unit of CobA activity was defined as the amount of enzyme required to generate 1 nmol of AdoCbl/min (13).

Cytochrome c Reductase Assays Activity of the Fpr protein was monitored using the cytochrome c reductase assay as reported by Fujii et al. (22, 23), except the assays were performed under anoxic conditions to mimic the conditions used in the corrinoid adenosylation assays.

1,2-Propanediol Dehydratase Assays In vitro assays for AdoCbl-dependent 1,2-propanediol dehydratase (a gift from Perry A. Frey) were performed as described (30). The conversion of 1,2-propanediol to propionaldehyde was measured by derivatization of the product with 3-methyl-2-benzothiazoline hydrazone yielding an azine product that can be measured spectrophotometrically at 305 nm (epsilon 305 = 13,300 M-1 cm-1). This assay was used as a measure of coenzymic activity of enzymically generated AdoCbl. One unit of 1,2-propanediol dehydratase is defined as the amount of enzyme required to generate 1 µmol of propionaldehyde/min under the conditions of the assay.

Synthesis of Aquocobinamide (H2OCbi) H2OCbi was synthesized in vitro from (CN)2Cbi. First, AdoCbi was synthesized from (CN)2Cbi using the potassium borohydride-dependent corrinoid adenosylation assays. The assays were performed as described (13), except (CN)2Cbi (50 µM) was substituted for HOCbl. After substrate conversion was complete, the reaction mixture was exposed to air and filtered through a 45-µm (25-mm diameter) syringe filter (Nalgene, Rochester, NY). The corrinoid product was isolated using a C18 SepPak cartridge (Waters, Milford, MA) and dried using a SpeedVac concentrator (Savant Instruments, Farmingdale, NY). Concentrated AdoCbi was resuspended in 400 µl of water and photolyzed aerobically using a tungsten/halogen lamp placed ~20 cm away from the tube containing the sample. Using this procedure, AdoCbi was converted by heterolysis to H2OCbi. The sample was passed through a C18 cartridge as described above. H2OCbi was converted to (CN)2Cbi by photolysis in 0.1 M KCN, pH 10.0, using a tungsten/halogen lamp and quantitated using the molar extinction coefficient for (CN)2Cbi at 367 nm (epsilon 367 = 30,800 M-1 cm-1) (31).

Reverse Phase HPLC (RP-HPLC) Analysis of Reaction Products The products of the corrinoid adenosylation assays were isolated and analyzed by RP-HPLC on a Prodigy ODS (8) column (Phenomenex, Torrance, CA) attached to an HPLC system as described (32). A photodiode array detector (Waters) was used to identify corrinoids by their UV-visible spectra. Authentic HOCbl and AdoCbl were used as standards. The isolated corrinoids were desalted using a C18 SepPak cartridge and dried in a SpeedVac concentrator.

Mass Spectrometry Mass spectrometry of purified reaction products was performed at the Mass Spectrometry Facility at the University of Wisconsin-Madison Biotechnology Center.

In Vivo Assessment of Adenosylcorrinoid Synthesis In vitro synthesis of adenosylcorrinoids was assessed in vivo by using strain JE1096 (metE205 ara-9 cobA343::MudJ) as an indicator strain in a biological activity assays. The cells of the indicator strain grown overnight in 2 ml of nutrient broth were concentrated by centrifugation and washed with 14.5 mM sterile saline; 0.1 ml of the cell suspension (~108 cells) was added to 3 ml of molten soft agar (0.7% w/v) and used to overlay a plate of Vogel-Bonner minimal medium (33) containing glucose (11 mM) as carbon and energy source. The corrinoid standards AdoCbi, (CN)2Cbi, and Cbl (~50 pmol each) and reaction products were spotted onto the overlay and incubated overnight at 37 °C.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Homogeneous Fpr, FldA, and CobA Proteins Are Sufficient for in Vitro Conversion of Cob(III)alamin to AdoCbl-- NADPH-dependent synthesis of AdoCbl was conducted when cell-free extracts of strains overexpressing Fpr (ferredoxin(flavodoxin):NADP+ oxidoreductase) and FldA (flavodoxin A) proteins were added to corrinoid adenosylation assay mixtures in place of potassium borohydride (data not shown). Control experiments in which either cell-free extract was omitted failed to yield a product, suggesting a requirement for both Fpr and FldA proteins. These proteins were isolated to homogeneity to further investigate their involvement the corrinoid adenosylation reaction.

Homogeneous Fpr protein (Fig. 2, lane A) used in this work had a cytochrome c reductase specific activity of 0.36 µmol cyt c min-1 mg-1 of protein, and a specific content of 42 nmol of Fpr/mg of protein. Initially, the cob(II)alamin substrate was generated using NAD(P)H:flavin oxidoreductase H6Fre enzyme, NADH, and FMN (20). Once the Fpr protein was isolated, it was used in lieu of H6Fre to reduce HOCbl to cob(II)alamin. Elimination of the H6Fre protein simplified the reaction conditions.


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Denaturing polyacrylamide gel electrophoretic analysis of purified of proteins required for in vitro corrinoid adenosylation. Lane A, homogeneous Fpr enzyme. Lane B, homogeneous FldA protein. Lane C, homogeneous CobA enzyme. Molecular mass standards are shown on the right (in kDa).

The FldA protein was purified to >95% homogeneity (Fig. 2, lane B). Approximately 85 mg of protein was obtained from 25 g of wet mass. The specific flavoprotein content for this preparation was 22 nmol of FldA/mg of protein. FldA protein was reduced by Fpr, and reduced FldA was coupled to CobA enzyme in the corrinoid adenosylation assays. This system converted cob(III)alamin or cob(III)inamide to their corresponding adenosylated derivatives. NADPH was required, but unlike other systems, no further addition of FAD or FMN to the reaction mixture was necessary (7, 8, 19, 20).

When Fpr and FldA proteins were coupled to the CobA enzyme, AdoCbl synthesis was observed (Fig. 3A). The characteristic changes associated with conversion of cob(II)alamin to the final product, AdoCbl (Fig. 3B), were not observed when either one of the enzymes was omitted from the reaction mixture. These spectral changes were in good agreement with those observed for this conversion in other systems (7). The identity of the products of these reactions was further confirmed by the analyses shown below.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   A, in vitro conversion of cob(III)alamin to AdoCbl by homogeneous Fpr, FldA, and CobA proteins. Coupled corrinoid adenosylation assays contained: 100 µmol of NADPH, 50 nmol of HOCbl, 400 nmol of ATP, 800 nmol of MnCl2, 50 nmol of FMN, 50 units of purified H6Fre enzyme, 4.7 nmol of purified Fpr enzyme, 3.2 nmol of purified FldA protein, and 1.4 nmol of purified CobA enzyme in Tris-Cl buffer, pH 8.0, at 37 °C (200 µmol). Spectrum 1, AdoCbl product of the complete reaction mixture; spectrum 2, cob(II)alamin product of a reaction in which the FldA protein was omitted; spectrum 3, cob(II)alamin product of a reaction in which the Fpr enzyme was omitted; spectrum 4, cob(II)alamin product of a reaction in which the CobA enzyme was omitted. B, spectral changes associated with the conversion of cob(III)alamin to AdoCbl. Protein concentrations were as follows: 0.7 nmol of Fpr; 2.1 nmol of FldA, and 0.9 nmol of CobA. Spectrum 1, UV-visible spectrum of the solution at the start of the reaction; spectrum 2, UV-visible spectrum of the solution 10 min after the reaction was started; spectrum 3, UV-visible spectrum of the solution 20 min after the reaction was started; spectrum 4, UV-visible spectrum of the solution 30 min after the reaction was started; spectrum 5, UV-visible spectrum of the solution one hr after the reaction was started. C, time course for the enzymic conversion of cob(III)alamin to AdoCbl. Protein concentrations were as follows: 0.7 nmol of Fpr, 2.1 nmol of FldA, and 0.5 nmol of CobA. The reaction conditions were as described under "Experimental Procedures."

Linearity of the Reaction-- The rate of product formation was linear when the concentration of the FldA protein in the reaction mixture ranged between 0.5 and 2.0 µM (0.2-0.4 nmol of AdoCbl min-1). The rate of the reaction was also linear when CobA enzyme was present in the reaction mixture in the range of 0.5-1.5 µM (0.2-0.5 nmol AdoCbl min-1). These results indicated a 1:1 CobA:FldA stoichiometry.

Identification of the Product of the Reaction-- The product of the corrinoid adenosylation reaction was isolated by RP-HPLC. When HOCbl was used as substrate, the elution time (Fig. 4A, 21.9 min) and UV-visible spectrum of the isolated product was identical to an AdoCbl standard isolated by the same procedure (Fig. 4B). When the reducing system (Fpr, FldA) was omitted from the reaction mixture, a product with an elution time (18.7 min) and UV-visible spectrum identical to that of a HOCbl standard was obtained (data not shown).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Isolation of the reaction product by RP-HPLC. A, elution profile of the reaction product of the coupled corrinoid adenosylation assays as isolated by RP-HPLC. The product of the reaction had an elution time of 21.9 min. Commercially available AdoCbl subjected to the same procedure eluted at 22.0 min (data not shown). B, UV-visible spectrum of the isolated corrinoid. Inset, UV-visible spectrum of authentic AdoCbl.

The isolated product was analyzed by electrospray ionization (ESI) mass spectrometry (Fig. 5). The positive-ion ESI mass spectrum showed signals with m/z values of 829.2 and 1582.2, which corresponded to masses of KAdoCbl (z = +2) and AdoCbl (z = +1), respectively. The negative-ion ESI mass spectrum of the product showed a parent peak with an m/z value 1367.8 (z = +1), in agreement with the molecular mass for NaHOCbl and suggesting that the Ado group was removed during analysis. This was confirmed by the negative-ion ESI mass spectrum of authentic AdoCbl isolated by HPLC (Fig. 5B). The positive ion ESI mass spectrum of authentic AdoCbl showed a signal at m/z = 829.4, consistent with the molecular masses of KAdoCbl (z = +2).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Mass spectrometry analysis of the product of the coupled corrinoid adenosylation assay. A, positive and negative ion ESI mass spectra of the reaction product isolated by RP-HPLC. B, positive and negative ion ESI mass spectra of authentic AdoCbl isolated by RP-HPLC.

AdoCbl Generated by the Enzymic System Has Coenzymic Activity-- Approximately 0.1 nmol of enzymically generated AdoCbl was added to 1,2-propanediol dehydratase reaction mixtures. The amount of propionaldehyde generated from the dehydration of 1,2-propanediol during the reaction was identical to that of a reaction performed using 0.1 nmol of commercially available AdoCbl (specific activity, 0.02 unit/mg), indicating that enzymically generated AdoCbl was biologically active.

In Vitro Reduction and Adenosylation of Cobinamide Derivatives-- Corrinoid adenosylation assays were performed using either (CN)2Cbi or H2OCbi as substrate. When (CN)2Cbi was used, the rate conversion of this substrate to AdoCbi was slow, as judged by the changes in the UV-visible spectrum associated with this conversion (Fig. 6A). High concentrations of the flavoprotein system and of the CobA enzyme were required to drive the reaction to near completion (Fig. 6A, spectrum 5). The UV-visible spectrum of the product obtained under these conditions was in good agreement with that reported for AdoCbi (13, 34). The absorbance peak at 579 nm (Fig. 6A, spectrum 5) was indicative of unreacted substrate. These results indicated that the cyanide ligands were removed upon reduction of the cobalt ion to generate the four-coordinate cob(I)inamide substrate for CobA. When H2OCbi was used as substrate (Fig. 6B), the apparent rate for adenosylation was approximately twice as fast, indicating that removal of the cyanide ligands was the rate-limiting step when (CN)2Cbi was used as substrate.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   In vitro reduction and adenosylation of cobinamide. A, spectral changes associated with the enzymic conversion of (CN)2Cbi to AdoCbi. Protein concentrations were as follows: 0.7 nmol of Fpr, 2.1 nmol of FldA, and 0.9 nmol of CobA. Spectrum 1, UV-visible spectrum of the starting substrate; spectrum 2, UV-visible spectrum of the solution upon addition of NADPH, Fpr, FldA, ATP, and CobA; spectrum 3, UV-visible spectrum of the solution 15 min after the reaction was started; spectrum 4, UV-visible spectrum of the solution 2 h after the reaction was started; spectrum 5, UV-visible spectrum of the product obtained after 12 h of incubation. Protein concentrations required to obtain this product were: 3.0 nmol of Fpr, 2.1 nmol of FldA, and 1.4 nmol of CobA. The remaining peak at 579 nm indicated incomplete conversion of the substrate under the conditions of the assay. B, spectral changes associated with the enzymic conversion of hydroxocob(III)inamide to AdoCbi. Protein concentrations were as follows: 0.7 nmol of Fpr, 2.1 nmol of FldA, and 0.9 nmol of CobA. Spectrum 1, UV-visible spectrum of the starting substrate HOCbl; spectrum 2, UV-visible spectrum of the solution upon addition of NADPH, Fpr, FldA, and CobA. spectrum 3, UV-visible spectrum of the solution upon addition of ATP and CobA; spectrum 4, UV-visible spectrum of the solution 30 min after the reaction was started; spectrum 5, UV-visible spectrum of the solution 1 h after the reaction was started.

To confirm that the product of the in vitro reaction was AdoCbi, strain JE1096 was used to test for biological activity (Fig. 7). Strain JE1096 is a methionine auxotroph correctable by AdoCbi or Cbl (11). A strong growth response was observed when the product of the reaction was provided to the indicator strain. Growth of the cobA mutant strain was also observed with AdoCbi generated in KBH4-dependent adenosylation assays (Fig. 7). As expected, a growth response was not observed when (CN)2Cbi was provided in the assay. These results confirmed that the product was AdoCbi.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 7.   In vivo assessment of adenosylcorrinoid synthesis. A biological activity assay was used to detect AdoCbi in the reaction mixture. The product of the reaction was provided to strain JE1096 (met205 ara-9 cobA343::MudJ). This strain is a methionine auxotroph unless AdoCbi or Cbl is provided in the medium. A growth response was observed when the product of the reaction is provided to the indicator strain. Authentic cyanocobalamin, (CN)2Cbi, and AdoCbi were provided as controls for the growth response.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The data reported herein show that the reducing system comprised of the Fpr and FldA proteins is sufficient for the generation of the co(I)rrinoid substrate of the ATP:co(I)rrinoid adenosyltransferase CobA enzyme of S. enterica. To the best of our knowledge, this is the first report of a reducing system that can be coupled to the CobA enzyme for the generation of adenosylated corrinoids.

The involvement of the FldA protein in the corrinoid adenosylation reaction is consistent with the ability of this protein to work at low redox potentials as a one-electron carrier (21, 22, 35, 36) and with its involvement in the reduction of cob(II)alamin to cob(I)alamin on the Cbl-dependent methionine synthase MetH enzyme (21-24, 37). The validity of the conclusions drawn from this work is not affected by the use of E. coli FldA and Fpr proteins given the high degree of identity shared by the proteins in these bacteria (Fig. 8), strongly suggesting that these proteins perform equivalent functions in these procaryotes. Thus it is reasonable to think that reduced FldA might represent a natural reducing system for corrinoid adenosylation in enterobacteria (e.g. E. coli and S. enterica).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 8.   Amino acid sequence alignments of the E. coli and S. enterica Fpr and FldA proteins. Sequence alignments were performed using the CLUSTAL W program (43). Sequences were also analyzed using the National Center for Biotechnology Information BLAST 2.0 program (44). Preliminary sequence information for S. enterica serovar Typhimurium LT2 was obtained from the Genome Sequencing Center (Washington University, St. Louis, MO) data base (Genome Sequencing Center, http://genome.wustl.edu/gsc/Blast/client.pl). Identical amino acid residues are marked by asterisks. Differences between sequences are highlighted in gray. A, E. coli Fpr versus S. enterica Fpr. B, E. coli FldA versus S. enterica FldA.

The Site of Corrinoid Reduction-- The very low redox potential of the free cob(II)alamin/cob(I)alamin couple (E°' = -610 mV) (38) and the extreme reactivity of the cob(I)alamin nucleophile (39) strongly suggest that reduction of cob(II)alamin occurs on the CobA enzyme. It is unlikely that cob(II)alamin reduction occurs in solution because the midpoint redox potentials for the semiquinone and hydroquinone forms of free FldA (-260 and -440 mV, respectively) (21) are too high to account for the generation of the cob(I)alamin nucleophile via a second order reaction. The redox potential for this reaction is expected to be close to the redox potential for free cob(II)alamin and thus considerably lower than that of the cob(II)alamin form of free methionine synthase (21, 38). In addition, the lower axial ligand of HOCbl has been shown to be coordinated to the cobalt in the CobA crystal structure (Fig. 8) (14). Generation of the cob(I)alamin substrate for CobA ligand would require lower ligand dissociation from the cobalt ion. This reaction is known to raise the redox potential of the cob(II)alamin/cob(I)alamin couple (21, 40). Interactions between FldA and CobA coupled to product formation are therefore expected to raise the redox potential to facilitate the reaction. The documented mechanisms for MetH reactivation as well as the FldA-dependent anaerobic ribonucleotide reductase activation reaction support this hypothesis (24, 41). Interactions between the FldA and CobA proteins are an attractive possibility, when one also considers the location of the corrinoid-binding site in CobA (14). The ternary complex structure between HOCbl, ATP, and CobA show that the corrinoid binding site is located near the surface of the enzyme (Fig. 9). The interactions between FldA and CobA and/or the reduction of the corrinoid may be responsible for the hypothesized conformational changes CobA must undergo to bring the target C5' of the ribose closer to the cobalt atom for the nucleophilic attack to occur (14). Work addressing these important aspects of the reaction is currently being performed.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 9.   Stereo view of the ternary complex between CobA, HOCbl and ATP (14). Shown is a ribbon representation of the complex between CobA and its substrates. Only one HOCbl molecule is observed in this representation, bound at the surface of subunit A. The N-terminal alpha -helix from subunit B is shown interacting with the nucleotide loop of the HOCbl molecule bound to subunit A. The lower ligand, 5,6-dimethylbenzimidazole, is shown coordinated to the cobalt ion of the corrin ring.

Is FldA Involved in Corrinoid Adenosylation in Vivo?-- The answer to this question is complicated by the fact that mutations in the fldA gene have been found to be lethal under aerobic and anaerobic growth conditions, suggesting that FldA is an essential function (42). Thus a genetic approach to this question is not possible. Because of this, we are not able to determine whether FldA is one redundant function in co(II)rrinoid reduction for adenosylation or whether it is solely responsible for this process. If FldA were an in vivo corrinoid reductase involved in corrinoid adenosylation, it would explain why cob(II)alamin reductase mutants have not been isolated. The chemistry of the reaction together with the data presented herein suggest that a true in vivo reductant for this process must be a low redox one-electron carrier and that, if the proposed interactions with the CobA enzyme are required, at least some specificity would be expected.

The Corrinoid Adenosylation Pathway in S. enterica-- The schematic of the corrinoid adenosylation pathway shown in Fig. 10 incorporates the findings reported in this paper. In this model, reduction of co(III)rrinoid to co(II)rrinoid is shown catalyzed by endogenous dihydroflavin nucleotides or by the Fpr enzyme. The Fpr enzyme uses NADPH to reduce FldA, which in turn transfers an electron to Co(II) to yield Co(I). Electrons for co(II)rrinoid reduction are proposed to be transferred by reduced FldA when the corrinoid is bound to the CobA enzyme. The nucleophilic attack by Co(I) on the C5' of the ribosyl moiety of ATP results in the release of inorganic tripolyphosphate.2 Putative interactions between the FldA and CobA proteins are currently under investigation.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 10.   The corrinoid adenosylation pathway in S. enterica. Electrons for reduction of co(III)rrinoids to co(I)rrinoids are donated by NADPH through flavins, Fpr, or FldA. The Fpr enzyme reduces FldA to the semiquinone form for generation of the co(I)rrinoid substrate of CobA. e-, electron; Fpr·FAD, oxidized form of Fpr; Fpr·FADH2, hydroquinone form of Fpr; FldA·FMN, oxidized form of FldA; FldA·FMNH·, semiquinone form of flavodoxin; PPPi, tripolyphosphate.


    ACKNOWLEDGEMENTS

We thank R. G. Matthews (University of Michigan) and E. Haggård-Ljungquist (Karolinska Institutet, Stockholm, Sweeden) for strains and plasmids. We thank P. A. Frey (University of Wisconsin-Madison, Biochemistry Department) for the gift of 1,2-propanediol dehydratase. We thank I. Rayment (University of Wisconsin-Madison, Biochemistry Department) for assistance in generating the stereo-view of the CobA enzyme. We thank R. Schwartz (University of Wisconsin-Madison, Bacteriology Department) for technical assistance. We thank the Genome Sequencing Center, Washington University, St. Louis, MO (http://genome.wustl.edu/gsc/Search/policy.shtml) for allowing access to S. enterica DNA sequence data prior to publication.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant GM40313 and by a DuPont Aid-To-Education grant (to J. C. E.-S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Use of this system is regulated by patent P00259US.

Dagger Recipient of a Minority Access to Research Careers (MARC) predoctoral fellowship GM17528.

§ To whom correspondence should be addressed: Dept. of Bacteriology, 1550 Linden Dr., Madison, WI 53706-1567. Tel.: 608-262-7379; Fax: 608-262-9865; E-mail: jcescala@facstaff.wisc.edu.

Published, JBC Papers in Press, June 14, 2001, DOI 10.1074/jbc.M102510200

2 M. V. Fonseca and J.C. Escalante-Semerena, unpublished results.

    ABBREVIATIONS

The abbreviations used are: AdoCbl, adenosylcobalamin; ATP, adenosine triphosphate; CNCbl, cyanocobalamin; RP-HPLC, reverse phase high performance, liquid chromatography; Cbl, cobalamin; (CN)2Cbi, diacyanocob(III)inamide; (H2OCbi), aquocob(III)inamide; FMN, flavin mononucleotide; NADPH, nicotinamide adenine dinucleotide phosphate, reduced form; Fre, NAD(P)H:flavin oxidoreductase (EC 1.6.8.1); H6Fre, hexahistidine-tagged Fre; Fpr, ferredoxin (flavodoxin):NADP+ reductase (EC 1.18.1.2); FldA, flavodoxin; CobA, ATP:co(I)rrinoid adenosyltransferase (EC 2.5.1.17); MetH, E. coli N10-methyltetrahydrofolate:homocysteine methyltransferase (methionine synthase, EC 2.1.1.13); 1, 2-propanediol dehydratase, DL-1,2-propanediol hydro-lyase. (EC 4.2.1.28); PAGE, polyacrylamide gel electrophoresis; FPLC, fast protein liquid chromatography; HOCbl, hydroxocob(III)alamin; ESI, electrospray ionization.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Battersby, A. R. (1994) Science 264, 1551-1557
2. Rondon, M. R., Trzebiatowski, J. R., and Escalante-Semerena, J. C. (1997) Prog. Nucleic Acids Res. Mol. Biol. 56, 347-384
3. Blanche, F., Cameron, B., Crouzet, J., Debussche, L., Thibaut, D., Vuilhorgne, M., Leeper, F. J., and Battersby, A. R. (1995) Angew. Chem. Int. Ed. Engl. 34, 383-411
4. Lawrence, J., and Roth, J. R. (1995) J. Bacteriol. 177, 6371-6380
5. Santander, P. J., Roessner, C. A., Stolowich, N., Holderman, M. T., and Scott, A. I. (1997) Chem. Biol. 4, 659-666
6. Raux, E., Thermes, C., Heathcote, P., Rambach, A., and Warren, M. J. (1997) J. Bacteriol. 179, 3202-3212
7. Walker, G. A., Murphy, S., and Huennekens, F. M. (1969) Arch. Biochem. Biophys. 134, 95-102
8. Brady, R. O., Castanera, E. G., and Barker, H. A. (1962) J. Biol. Chem. 223, 2325-2332
9. Vitols, E., Walker, G. A., and Huennekens, F. M. (1966) J. Biol. Chem. 241, 1455-1461
10. Debussche, L., Couder, M., Thibaut, D., Cameron, B., Crouzet, J., and Blanche, F. (1991) J. Bacteriol. 173, 6300-6302
11. Escalante-Semerena, J. C., Suh, S.-J., and Roth, J. R. (1990) J. Bacteriol. 172, 273-280
12. Suh, S.-J., and Escalante-Semerena, J. C. (1993) Gene (Amst.) 129, 93-97
13. Suh, S.-J., and Escalante-Semerena, J. C. (1995) J. Bacteriol. 177, 921-925
14. Bauer, C. B., Fonseca, M. V., Holden, H. M., Thoden, J. B., Thompson, T. B., Escalante-Semerena, J. C., and Rayment, I. (2001) Biochemistry 40, 361-374
15. Drennan, C. L., Huang, S., Drummond, J. T., Matthews, R. G., and Ludwig, M. L. (1994) Science 266, 1660-1674
16. Mancia, F., Keep, N. H., Nakagawa, A., Leadlay, P. F., McSweeney, S., Rasmussen, B., Bösecke, P., Diat, O., and Evans, P. R. (1996) Structure 4, 339-350
17. Shibata, N., Masuda, J., Tobimatsu, T., Toraya, T., Suto, K., Morimoto, Y., and Yasuoka, N. (1999) Structure Fold Des. 7, 997-1008
18. Reitzer, R., Gruber, K., Jogl, G., Wagner, U. G., Bothe, H., Buckel, W., and Kratky, C. (1999) Structure Fold Des. 7, 891-902
19. Blanche, F., Maton, L., Debussche, L., and Thibaut, D. (1992) J. Bacteriol. 174, 7452-7454
20. Fonseca, M. V., and Escalante-Semerena, J. C. (2000) J. Bacteriol. 182, 4304-4309
21. Hoover, D. M., Jarrett, J. T., Sands, R. H., Dunham, W. R., Ludwig, M. L., and Matthews, R. G. (1997) Biochemistry 36, 127-138
22. Fujii, K., and Huennekens, F. M. (1974) J. Biol. Chem. 249, 6745-6753
23. Fujii, K., Galivan, J. H., and Huennekens, F. M. (1977) Arch. Biochem. Biophys. 178, 662-670
24. Jarrett, J. T., Hoover, D. M., Ludwig, M. L., and Matthews, R. G. (1998) Biochemistry 37, 12649-12658
25. Hall, D. A., Jordan-Starck, T. C., Loo, R. O., Ludwig, M. L., and Matthews, R. G. (2000) Biochemistry 39, 10711-10719
26. Bradford, M. M. (1976) Anal. Biochem. 72, 248-255
27. Laemmli, U. K. (1970) Nature 227, 680-685
28. Sasse, J. (1991) in Current Protocols in Molecular Biology (Ausubel, F. A. , Brent, R. , Kingston, R. E. , Moore, D. D. , Seidman, J. G. , Smith, J. A. , and Struhl, K., eds), Vol. 1 , pp. 10.6.1-10.6.8, Wiley Interscience, New York
29. Hoover, D. M., and Ludwig, M. L. (1997) Protein Sci 6, 2525-2537
30. Toraya, T., Ushio, K., Fukui, S., and Hogenkamp, P. C. (1977) J. Biol. Chem. 252, 963-970
31. Hogenkamp, H. P. C. (1975) in Cobalamin: Biochemistry and Pathophysiology (Babior, B. M., ed) , pp. 21-74, John Wiley & Sons, New York
32. O'Toole, G. A., Rondon, M. R., and Escalante-Semerena, J. C. (1993) J. Bacteriol. 175, 3317-3326
33. Vogel, H. J., and Bonner, D. M. (1956) J. Biol. Chem. 218, 97-106
34. Thomas, M. G., and Escalante-Semerena, J. C. (2000) J. Bacteriol. 182, 4227-4233
35. Vetter, H., Jr., and Knappe, J. (1971) Hoppe-Seyler's Z. Physiol. Chem. 352, 433-446
36. Vervoort, J., Muller, F., LeGall, J., Bacher, A., and Sedlmaier, H. (1985) Eur. J. Biochem. 151, 49-57
37. Jarrett, J. T., Huang, S., and Matthews, R. G. (1998) Biochemistry 37, 5372-5382
38. Banerjee, R. V., Harder, S. R., Ragsdale, S. W., and Matthews, R. G. (1990) Biochemistry 29, 1129-1135
39. Schrauzer, G. N., Deutsch, E., and Windgassen, R. J. (1968) J. Am. Chem. Soc. 90, 2441-2442
40. Lexa, D., and Saveant, J.-M. (1983) Acc. Chem. Res. 16, 235-243
41. Mulliez, E., Padovani, D., Atta, M., Alcouffe, C., and Fontecave, M. (2001) Biochemistry 40, 3730-3736
42. Gaudu, P., and Weiss, B. (2000) J. Bacteriol. 182, 1788-1793
43. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680
44. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Miller, W., and Lipmann, D. J. (1997) Nucleic Acids Res. 25, 3389-3402


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. D. Lawrence, E. Deery, K. J. McLean, A. W. Munro, R. W. Pickersgill, S. E. J. Rigby, and M. J. Warren
Identification, Characterization, and Structure/Function Analysis of a Corrin Reductase Involved in Adenosylcobalamin Biosynthesis
J. Biol. Chem., April 18, 2008; 283(16): 10813 - 10821.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
J. C. Escalante-Semerena
Conversion of Cobinamide into Adenosylcobamide in Bacteria and Archaea
J. Bacteriol., July 1, 2007; 189(13): 4555 - 4560.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. St. Maurice, P. E. Mera, M. P. Taranto, F. Sesma, J. C. Escalante-Semerena, and I. Rayment
Structural Characterization of the Active Site of the PduO-Type ATP:Co(I)rrinoid Adenosyltransferase from Lactobacillus reuteri
J. Biol. Chem., January 26, 2007; 282(4): 2596 - 2605.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. R. Buan and J. C. Escalante-Semerena
Purification and Initial Biochemical Characterization of ATP:Cob(I)alamin Adenosyltransferase (EutT) Enzyme of Salmonella enterica
J. Biol. Chem., June 23, 2006; 281(25): 16971 - 16977.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
N. R. Buan, K. Rehfeld, and J. C. Escalante-Semerena
Studies of the CobA-Type ATP:Co(I)rrinoid Adenosyltransferase Enzyme of Methanosarcina mazei Strain Go1.
J. Bacteriol., May 1, 2006; 188(10): 3543 - 3550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. R. Buan and J. C. Escalante-Semerena
Computer-assisted Docking of Flavodoxin with the ATP:Co(I)rrinoid Adenosyltransferase (CobA) Enzyme Reveals Residues Critical for Protein-Protein Interactions but Not for Catalysis
J. Biol. Chem., December 9, 2005; 280(49): 40948 - 40956.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
E. M. Sampson, C. L. V. Johnson, and T. A. Bobik
Biochemical evidence that the pduS gene encodes a bifunctional cobalamin reductase
Microbiology, April 1, 2005; 151(4): 1169 - 1177.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Leal, H. Olteanu, R. Banerjee, and T. A. Bobik
Human ATP:Cob(I)alamin Adenosyltransferase and Its Interaction with Methionine Synthase Reductase
J. Biol. Chem., November 12, 2004; 279(46): 47536 - 47542.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
N. R. Buan, S.-J. Suh, and J. C. Escalante-Semerena
The eutT Gene of Salmonella enterica Encodes an Oxygen-Labile, Metal-Containing ATP:Corrinoid Adenosyltransferase Enzyme
J. Bacteriol., September 1, 2004; 186(17): 5708 - 5714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Saridakis, A. Yakunin, X. Xu, P. Anandakumar, M. Pennycooke, J. Gu, F. Cheung, J. M. Lew, R. Sanishvili, A. Joachimiak, et al.
The Structural Basis for Methylmalonic Aciduria: THE CRYSTAL STRUCTURE OF ARCHAEAL ATP:COBALAMIN ADENOSYLTRANSFERASE
J. Biol. Chem., May 28, 2004; 279(22): 23646 - 23653.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Woodson and J. C. Escalante-Semerena
CbiZ, an amidohydrolase enzyme required for salvaging the coenzyme B12 precursor cobinamide in archaea
PNAS, March 9, 2004; 101(10): 3591 - 3596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Rodionov, A. G. Vitreschak, A. A. Mironov, and M. S. Gelfand
Comparative Genomics of the Vitamin B12 Metabolism and Regulation in Prokaryotes
J. Biol. Chem., October 17, 2003; 278(42): 41148 - 41159.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
J. D. Woodson, R. F. Peck, M. P. Krebs, and J. C. Escalante-Semerena
The cobY Gene of the Archaeon Halobacterium sp. Strain NRC-1 Is Required for De Novo Cobamide Synthesis
J. Bacteriol., January 1, 2003; 185(1): 311 - 316.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. M. Dobson, T. Wai, D. Leclerc, H. Kadir, M. Narang, J. P. Lerner-Ellis, T. J. Hudson, D. S. Rosenblatt, and R. A. Gravel
Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria
Hum. Mol. Genet., December 15, 2002; 11(26): 3361 - 3369.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. V. Fonseca, N. R. Buan, A. R. Horswill, I. Rayment, and J. C. Escalante-Semerena
The ATP:Co(I)rrinoid Adenosyltransferase (CobA) Enzyme of Salmonella enterica Requires the 2'-OH Group of ATP for Function and Yields Inorganic Triphosphate as Its Reaction Byproduct
J. Biol. Chem., August 30, 2002; 277(36): 33127 - 33131.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/34/32101    most recent
M102510200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fonseca, M. V.
Right arrow Articles by Escalante-Semerena, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fonseca, M. V.
Right arrow Articles by Escalante-Semerena, J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement